Fulcrum Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $238k | 26k | 9.20 |
| 2025-06-30 | $224k | 33k | 6.88 |
| 2025-03-31 | $51k | 18k | 2.88 |
| 2024-12-31 | $189k | 40k | 4.70 |
| 2024-09-30 | $58k | 16k | 3.57 |
| 2024-06-30 | $99k | 16k | 6.20 |
| 2023-03-31 | $79k | 28k | 2.85 |
| 2022-12-31 | $138k | 19k | 7.28 |
| 2022-09-30 | $153k | 19k | 8.09 |
| 2022-03-31 | $355k | 15k | 23.65 |
| 2021-12-31 | $169k | 9.6k | 17.69 |
| 2021-09-30 | $270k | 9.6k | 28.26 |
| 2020-06-30 | $115k | 6.3k | 18.29 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors